bpc 157 intramuscular or subcutaneous bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA Where To Inject Bpc 157
Description
Supporting barrier integrity and improves microcirculation
Because knowing what to expect, and what to do when the unexpected happens, is the difference between abandoning a promising protocol and optimizing it for your goals
Any excess is stored in the liver or excreted in the urine
The rest of this guide covers the reasoning behind each rule, the edge cases, and exactly how to handle BAC water at every stage of a peptide protocol
